Literature DB >> 1320125

Ovarian cancer family and prophylactic choices.

D G Evans1, G Ribiero, D Warrell, D Donnai.   

Abstract

A subject from a family with ovarian cancer who has developed bilateral medullary carcinoma of the breast at the age of 40 is presented. The family is consistent with dominant inheritance of ovarian cancer and 12 female family members at 12.5%, 25%, and 50% risk, including our case, have undergone bilateral prophylactic oophorectomy and been given hormone replacement therapy. Despite the risk of further primary tumours of the breast our patient chose to have treatment with wide excision and radiotherapy. The implications for screening, prophylaxis, and hormone replacement therapy for this family are discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1320125      PMCID: PMC1015994          DOI: 10.1136/jmg.29.6.416

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  13 in total

1.  Ovarian cancer in mother and five daughters.

Authors:  A F LIBER
Journal:  AMA Arch Pathol       Date:  1950-03

2.  Age at onset as an indicator of familial risk of breast cancer.

Authors:  E B Claus; N J Risch; W D Thompson
Journal:  Am J Epidemiol       Date:  1990-06       Impact factor: 4.897

3.  Medullary carcinoma of the breast: a clinicopathologic study with 10 year follow-up.

Authors:  R L Ridolfi; P P Rosen; A Port; D Kinne; V Miké
Journal:  Cancer       Date:  1977-10       Impact factor: 6.860

Review 4.  The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer.

Authors:  T J Key; M C Pike
Journal:  Eur J Cancer Clin Oncol       Date:  1988-01

5.  Multimodal approach to screening for ovarian cancer.

Authors:  I Jacobs; I Stabile; J Bridges; P Kemsley; C Reynolds; J Grudzinskas; D Oram
Journal:  Lancet       Date:  1988-02-06       Impact factor: 79.321

6.  Six families prone to ovarian cancer.

Authors:  J F Fraumeni; G W Grundy; E T Creagan; R B Everson
Journal:  Cancer       Date:  1975-08       Impact factor: 6.860

7.  Familial association of breast/ovarian carcinoma.

Authors:  H T Lynch; R E Harris; H A Guirgis; K Maloney; L L Carmody; J F Lynch
Journal:  Cancer       Date:  1978-04       Impact factor: 6.860

8.  Transabdominal ultrasound screening for early ovarian cancer.

Authors:  S Campbell; V Bhan; P Royston; M I Whitehead; W P Collins
Journal:  BMJ       Date:  1989-12-02

9.  Transvaginal colour flow imaging: a possible new screening technique for ovarian cancer.

Authors:  T Bourne; S Campbell; C Steer; M I Whitehead; W P Collins
Journal:  BMJ       Date:  1989-12-02

10.  Relationship of epithelial ovarian cancer to other malignancies within families.

Authors:  J M Schildkraut; W D Thompson
Journal:  Genet Epidemiol       Date:  1988       Impact factor: 2.135

View more
  5 in total

1.  Counseling families with hereditary breast and ovarian cancer: A psychosocial perspective.

Authors:  M P Richards; N Hallowell; J M Green; F Murton; H Statham
Journal:  J Genet Couns       Date:  1995-09       Impact factor: 2.537

2.  Ascertainment of familial ovarian cancer in the Aberdeen Genetic Clinic.

Authors:  H Gregory; A Schofield; D de Silva; J Semper; B Milner; L Allan; N Haites
Journal:  J Med Genet       Date:  1996-03       Impact factor: 6.318

Review 3.  Familial breast cancer.

Authors:  D G Evans; I S Fentiman; K McPherson; D Asbury; B A Ponder; A Howell
Journal:  BMJ       Date:  1994-01-15

4.  A sociobehavioural perspective on genetic testing and counselling for heritable breast, ovarian and colon cancer.

Authors:  K G Macdonald; B Doan; M Kelner; K M Taylor
Journal:  CMAJ       Date:  1996-02-15       Impact factor: 8.262

5.  Specialist oncological surgery for removal of the ovaries and fallopian tubes in BRCA1 and BRCA2 pathogenic variant carriers may reduce primary peritoneal cancer risk to very low levels.

Authors:  Emma J Crosbie; Nicola Flaum; Elaine F Harkness; Richard D Clayton; Cathrine Holland; Pierre Martin-Hirsch; Nick Wood; Patrick Keating; Emma R Woodward; Fiona Lalloo; Paul Donnai; Richard J Edmondson; D Gareth Evans
Journal:  Int J Cancer       Date:  2020-11-11       Impact factor: 7.396

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.